Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say

(MedPage Today) — A new treatment algorithm from the European Association for the Study of Obesity (EASO) recommends opting for semaglutide (Wegovy) or tirzepatide (Zepbound) first when “substantial” weight loss is needed in a patient.
The two…